Systematic Reviews
Copyright ©The Author(s) 2015.
World J Gastroenterol. Nov 7, 2015; 21(41): 11862-11876
Published online Nov 7, 2015. doi: 10.3748/wjg.v21.i41.11862
Table 2 The ABCB1, ABCC2 and ABCG2 mRNA levels in intestinal tissue from patients with adenomas and colorectal cancer and healthy individuals
Unaffected tissueP value1Adenomas/carcinomasP value1P value2Ref.
ABCB1[13]
Healthy individuals0.012 ± 0.008
Mild/moderate dysplasia cases0.009 ± 0.004NS0.005 ± 0.004< 0.050< 0.001
Severe dysplasia cases0.009 ± 0.030NS0.003 ± 0.002< 0.050< 0.001
Cancer patients0.009 ± 0.014 (distant)< 0.050.003 ± 0.005< 0.001< 0.001
0.007 ± 0.009 (adjacent)< 0.05< 0.010
ABCC2[14]
Healthy individuals5.35 ± 3.24
Mild moderate dysplasia cases4.62 ± 4.790.0816.68 ± 6.770.870.037
Severe dysplasia cases6.66 ± 8.470.88010.18 ± 11.520.270.240
Cancer patients28.06 ± 68.84 (distant)0.03687.50 ± 270.210.00460.0037
11.44 ± 25.58 (adjacent)0.690< 0.0001
ABCG2[14]
Healthy individuals718.06 ± 761.24
Mild moderate dysplasia732.85 ± 2305.280.55056.02 ± 118.42< 0.0001< 0.0001
Severe dysplasia448.02 ± 195.340.84076.31 ± 102.63< 0.0001< 0.0001
Cancer patients6679 ± 58353 (distant)0.08098.41 ± 476.36< 0.0001< 0.0001
1302 ± 10090 (adjacent)0.011< 0.0001